3mhk
From Proteopedia
m (Protected "3mhk" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3mhk.png|left|200px]] | [[Image:3mhk.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3mhk", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3mhk| PDB=3mhk | SCENE= }} | {{STRUCTURE_3mhk| PDB=3mhk | SCENE= }} | ||
===Human tankyrase 2 - catalytic PARP domain in complex with 2-(2-pyridyl)-7,8-dihydro-5h-thiino[4,3-d]pyrimidin-4-ol=== | ===Human tankyrase 2 - catalytic PARP domain in complex with 2-(2-pyridyl)-7,8-dihydro-5h-thiino[4,3-d]pyrimidin-4-ol=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_22343925}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 22343925 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_22343925}} | {{ABSTRACT_PUBMED_22343925}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
| - | *[[Poly (ADP-ribose) polymerase]] | + | *[[Poly (ADP-ribose) polymerase|Poly (ADP-ribose) polymerase]] |
==Reference== | ==Reference== | ||
Revision as of 00:21, 27 July 2012
Contents |
Human tankyrase 2 - catalytic PARP domain in complex with 2-(2-pyridyl)-7,8-dihydro-5h-thiino[4,3-d]pyrimidin-4-ol
Template:ABSTRACT PUBMED 22343925
About this Structure
3mhk is a 1 chain structure of Poly (ADP-ribose) polymerase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Wahlberg E, Karlberg T, Kouznetsova E, Markova N, Macchiarulo A, Thorsell AG, Pol E, Frostell A, Ekblad T, Oncu D, Kull B, Robertson GM, Pellicciari R, Schuler H, Weigelt J. Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors. Nat Biotechnol. 2012 Feb 19. doi: 10.1038/nbt.2121. PMID:22343925 doi:10.1038/nbt.2121
Categories: Homo sapiens | Arrowsmith, C H. | Berg, S Van Den. | Berglund, H. | Bountra, C. | Collins, R. | Edwards, A M. | Flodin, S. | Flores, A. | Graslund, S. | Hammarstrom, M. | Johansson, I. | Karlberg, T. | Kotenyova, T. | Markova, N. | Moche, M. | Nordlund, P. | Nyman, T. | Persson, C. | SGC, Structural Genomics Consortium. | Schuler, H. | Schutz, P. | Siponen, M I. | Svensson, L. | Thorsell, A G. | Tresaugues, L. | Weigelt, J. | Welin, M. | Wisniewska, M. | Adp-ribosylation | Ank repeat | Catalytic fragment | Chromosomal protein | Glycosyltransferase | Golgi apparatus | Membrane | Mrna transport | Nad | Nucleus | Parp | Phosphorylation | Protein transport | Sgc | Structural genomic | Structural genomics consortium | Telomere | Transferase | Translocation | Transport | Wnt-signalling
